(Q45012662)

8 December 2017

title

Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study (English)

1 reference

8 December 2017

4

1 reference

8 December 2017

Gunnar Lindberg

1

1 reference

8 December 2017

Ulf Lindblad

2

1 reference

8 December 2017

Bent Löw-Larsen

3

1 reference

8 December 2017

Arne Melander

5

1 reference

8 December 2017

Lennart Råstam

6

1 reference

8 December 2017

language of work or name

1 reference

1 September 2002

1 reference

Pharmacoepidemiology and Drug Safety

8 December 2017

published in

1 reference

8 December 2017

volume

11

1 reference

8 December 2017

issue

6

1 reference

8 December 2017

page(s)

493-497

1 reference

The calcium-channel blocker controversy: historical perspective and important lessons for future pharmacotherapies. An international society of pharmacoepidemiology 'hot topic'.

8 December 2017

cites work

1 reference

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

Cancer risk in users of calcium channel blockers

21 January 2018

1 reference

Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978.

21 January 2018

1 reference

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.737

1 reference

8 December 2017

1 reference